More from Dr. Fauci
- FDA working with Gilead on approval for a drug that would be used for hospitalized patients,
- Has no timeline on FDA approval
This idea was floated earlier in the day. Hearing it from Dr. Fauci gives it more credibility.
Gilead stock has moved to a new session highs at $84.75.
The S&P index is just off its highs at 2941.45. The NASDAQ index is also just off its highs at 8895.266 (currently trading at 8893)